Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Inventory (2024 - 2025)

Day One Biopharmaceuticals (DAWN) has disclosed Inventory for 2 consecutive years, with $6.3 million as the latest value for Q4 2025.

  • Quarterly Inventory rose 90.48% to $6.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.3 million through Dec 2025, up 90.48% year-over-year, with the annual reading at $6.3 million for FY2025, 90.48% up from the prior year.
  • Inventory for Q4 2025 was $6.3 million at Day One Biopharmaceuticals, down from $7.1 million in the prior quarter.
  • The five-year high for Inventory was $7.1 million in Q3 2025, with the low at $151000.0 in Q2 2024.